← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Teradyne converted a semiconductor-test recovery into double-digit growth and a 20% margin, but free cash flow declined and the earnings-quality screen remained grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 13.1%OK
- Profitability — Net income grew 2.2% to $554.047M from $542.372MOK
- Cash flow — Free cash flow declined 5.0% to $450.406M from $474.081MWatch
- Margins — Operating margin contracted 68 bps to 20.38%Watch
- Accounting — Test-equipment recovery with softer conversionNote
- Insiders — 0 purchases and 29 salesWatch
Business
Teradyne supplies automated test equipment and industrial automation products.
Where the revenue comes from
Fiscal 2025, as TERADYNE, INC reports it. History and quarterly detail are in the app.
- Semiconductor Test$2.5B
- Product Test$358.0M
- Robotics$308.3M
Leadership changes
From TERADYNE, INC's own filings, the day they're filed.
- Michelle Turner · President · appointmenteff. 2025-11-03
- Sanjay Mehta · President · appointmenteff. 2025-11-03
- Necip Sayiner · directors · appointmenteff. 2025-07-01
Latest filings
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-05-11
- 10-Q · Quarterly report2026-05-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about TERADYNE, INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.